| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |